The Science + Technology Park at Johns Hopkins

A new center for biomedical research

The John G. Rangos Sr. Family Charitable Foundation has committed $10 million to the Institute for Basic Biomedical Sciences (IBBS) at Johns Hopkins University in Baltimore, MD. The gift dovetails with a long-term urban redevelopment project to build a biotech park called The Science + Technology Park at Johns Hopkins. In addition to the new university space, plans for the park include business offices, housing and retail stores. Now under construction, the six-story John G. Rangos Sr. Building will become the point building in the complex, with Johns Hopkins University as the anchor tenant occupying a third of the space for the IBBS research labs and offices. The remaining space will be leased to private biotech companies. Inspired by many great medical doctors and scientists at Johns Hopkins, John G. Rangos Sr. is pleased that parts of the new facility will be named after them. Dr. Horst Schirmer, Dr. Francis Mulligan and the late Dr. Charles Segal will all be honored with namesake sections within the new facility. Set to open in 2008, the unique complex will foster collaboration between scientists from different disciplines and industries to perform the types of research necessary to achieve medical breakthroughs. The point building will not only bear the Rangos name, it will also display a plaque that is true to the foundation’s philosophy of providing medical resources to create a healthier world. The plaque reads, "A building to combine the strength of industry with basic medical science to improve human health." When complete, the Science + Technology Park will be the site of five life-sciences buildings.

The John G. Rangos Professorship

In support of medical research, John G. Rangos Sr. established a professorship at Johns Hopkins University in the School of Medicine’s Division of Gastroenterology. The move supports new research initiatives in colon cancer. Dr. Francis Giardiello, professor of medicine, oncology and pathology, is the inaugural professor of the program. Dr. Giardiello participated in the discovery of the first colorectal cancer susceptibility gene mutation, which may become a valuable predictive marker of an individual’s risk for developing the disease.

Click here to read the Fall 2006 Hopkins Medical article, “Nexus for Excellence”